Type 7: Separate Products Requiring Cross Labeling

Preferred Label : Type 7: Separate Products Requiring Cross Labeling;

NCIt definition : Products meeting the definition at 21 CFR 3.2(e)(3) or (4) comprised of a separately marketed drug, device, and/ or biological product, such as certain light-activated drugs and associated light sources.;

Détails

Origin ID

C102840;

UMLS CUI

C3640958;

Semantic type(s)
- Manufactured Object [UMLS semantic type]
concept_is_in_subset
- FDA Structured Product Labeling Terminology [NCIt concept]
- SPL Combination Product Type Terminology [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

All resources
or only the major
or use the search engine

recommendations
documents concerning education
documents for patients